STOCK TITAN
  1. Home
  2. News
  3. OGI

Organigram Holdings Inc. - $OGI STOCK NEWS

Welcome to our dedicated page for Organigram Holdings news (Ticker: $OGI), a resource for investors and traders seeking the latest updates and insights on Organigram Holdings stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Organigram Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Organigram Holdings's position in the market.

News
Organigram Wins KIND Magazine’s Innovation of the Year for SHRED X Rip-Strips Hash
Rhea-AI Summary
Organigram Holdings Inc. (OGI) has won KIND Magazine’s 'Innovation of the Year' award for its SHRED X Rip-Strips Hash, marking the second consecutive win for the company. The award recognizes Organigram's commitment to consumer-focused innovation in the cannabis sector. The company was also nominated in four other categories, showcasing its strong presence and product offerings in the industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.56%
Tags
none
-
News
Organigram Increases Investment in Phylos After Successful Milestone Achievement
Rhea-AI Summary
Organigram Holdings Inc. (OGI) advances grow room conversion with custom designed F1 Hybrid seeds, aiming to reduce cultivation costs and produce high-potency, terpene-rich cultivars. The company has closed the second tranche of a loan agreement with Phylos Bioscience Inc., advancing US$2.75 million to further its cannabis genetics research and development. Organigram is on track to convert over 30% of its Moncton facility's cultivation space to F1 Hybrid seed grow by the end of FY24.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.6%
Tags
none
-
News
Organigram Announces Interim Chief Financial Officer
Rhea-AI Summary
Organigram Holdings Inc. (OGI) announces Derrick West's transition away from his role as CFO to focus on health and recovery. Paolo De Luca appointed as interim CFO while the company searches for a permanent replacement. CEO Goldenberg expresses gratitude for West's contributions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.03%
Tags
none
News
Organigram Announces C$124.6 Million Investment from BAT and Creation of “Jupiter” Strategic Investment Pool
Rhea-AI Summary
Organigram Holdings Inc. announces a C$124.6 million investment from BT DE Investments Inc., a subsidiary of BAT. The investment will be used to create a strategic investment pool called Jupiter, expand Organigram's geographic footprint, and enhance the product development collaboration between BAT and Organigram. BAT's voting Common Share ownership position will increase to 30% and overall equity interest to 45%. The investment strengthens Organigram's financial position and enables long-term growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.19%
Tags
none
-
News
Organigram Provides Corporate Update
Rhea-AI Summary
Organigram Holdings achieves #2 market share position in the last two months driven by success in pre-roll business and category leadership in hash and gummies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5%
Tags
none
-
News
Organigram Holdings Inc. Files Final Base Shelf Prospectus
Rhea-AI Summary
Organigram Holdings obtains receipt for final short form base shelf prospectus
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.5%
Tags
none
News
Organigram Holdings Inc. Files Preliminary Base Shelf Prospectus
Rhea-AI Summary
Organigram Holdings Inc. has filed a preliminary short form base shelf prospectus, allowing them to distribute up to C$500,000,000 of securities. This provides flexibility for financing options to pursue the company's objectives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.38%
Tags
none
-
News
Organigram Announces Resignation of Board Member
Rhea-AI Summary
Caroline Ferland resigns from Organigram's Board of Directors, leaving for a new role at BAT. She made considerable contributions to the company. BAT expects to appoint a replacement nominee.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
-
News
Organigram Launches First Range of THCV Products Derived from Moncton-Grown Whole Flower
Rhea-AI Summary
Organigram launches its first range of THCV products through its SHRED and Trailblazer brands, thanks to its strategic investment in Phylos Bioscience. Organigram is the only Canadian licensed producer to cultivate and extract THCV in-house. THCV is gaining popularity for its appetite suppressing effects and non-psychoactive properties. Organigram has exclusive Canadian rights to high-THCV cultivars from Phylos. The company's THCV products include SHRED'ems Guava Lime Go-Time and Trailblazer Zen Garden Grapefruit, offering unique cannabinoid experiences with high THC:THCV ratios.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.88%
Tags
none
News
Organigram Relaunches one of Canada’s First Cannabis Brands, Trailblazer
Rhea-AI Summary
Organigram relaunches Trailblazer brand with new product lineup targeting a $1.2B segment of the cannabis market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.1%
Tags
none
Stock OGI logo
Organigram Holdings Inc.

Nasdaq:OGI

OGI Rankings

#3758 Ranked by Market Cap
#5242 Ranked by Stock Gains
N/A Ranked by Dividends

OGI Stock Data

209.09M
68.41M
27.32%
8.8%
3.79%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States of America
Toronto

About OGI

as part of canada’s marihuana for medical purposes regulations (mmpr), organigram (tsx-v:ogi) is atlantic canada's original licensed producer of medical marijuana. we are dedicated to consistently providing our clients with the highest quality, organically grown medicine and service. if you have questions or want to learn more, visit www.organigram.ca or give our client services team a call at 1-855-961-9420.